BriaCell to Partner With Top U.S. Medical Institution Washington University to Produce Its BriaVax(TM) Cancer Vaccine - Seite 2

Dr. Charles Wiseman commented, "This is a major near-term milestone for BriaCell, in my mind second only to the FDA approving our planned trial, something we eagerly await. We are partnering with a renowned institution on favorable business terms. We must thank Washington University, as they have allowed BriaCell to obtain a top-notch cGMP facility, while leaving us with a strong balance sheet. I have a deep personal respect for Washington University, having myself completed a residency there many years ago. It is without a doubt one of the finest medical institutions in the country, and we are excited about this partnership. More importantly perhaps, we would like to hope Washington University is as excited as we are."

BACKGROUND ON WASHINGTON UNIVERSITY
Washington University in St. Louis was ranked the #1 Medical School in the United States with regards to Primary Care. U.S. News released this ranking in their 2015 report. U.S. News also ranked United States medical schools with regards to Research. In this report, Washington University ranked #6 in the United States, behind only Harvard, Stanford, Johns Hopkins, UCSF, and UPenn.

Washington University has a rich history, and its alumni include an array of Nobel Laureates in Medicine. Many top scientists and oncologists began their careers at Washington University, including BriaCell's own Founder Dr. Charles Wiseman.

Washington University's Siteman Comprehensive Cancer Center is an international leader in cancer treatment, research, prevention, education and community outreach. It is the only cancer center in the state to hold the prestigious Comprehensive Cancer Center designation from the National Cancer Institute and membership in the National Comprehensive Cancer Network

Washington University's Siteman Comprehensive Cancer Center was awarded "comprehensive" status because of its strong basic and clinical research programs; programs in cancer prevention, control and population-based research; and a body of interactive research bridging these areas. Siteman also was recognized for outreach and education efforts aimed at residents of the St. Louis region and health-care professionals.